Oral Methadone for Chronic Noncancer Pain: A Systematic Literature Review of Reasons for Administration, Prescription Patterns, Effectiveness, and Side Effects

Objective:To assess the indications, prescription patterns, effectiveness, and side effects of oral methadone for the treatment of chronic noncancer pain. Methods:We conducted searches of several electronic databases, textbooks and reference lists for controlled or uncontrolled studies in humans. Effectiveness was assessed using a dichotomous classification of “meaningful” versus “nonmeaningful” outcomes. Results:Twenty-one papers (1 small randomized trial, 13 case reports, and 7 case series) involving 545 patients with multiple noncancer pain conditions were included. In half of the patients, no specific diagnosis was reported. Methadone was administered primarily when previous opioid treatment was ineffective or produced intolerable side effects. Starting dose ranged from 0.2 to 80 mg/day and maximum dose ranged from 20 to 930 mg/day. Pain outcomes were meaningful in 59% of the patients in the uncontrolled studies. The randomized trial demonstrated a statistically significant improvement in pain for methadone (20 mg/day) compared to placebo. Side effects were considered minor. Discussion:Oral methadone is used for various noncancer pain syndromes, at different settings and with no prescription pattern that could be identifiable. Starting, maintenance, and maximum doses showed great variability. The figure of 59% effectiveness of methadone should be interpreted very cautiously, as it seems overrated due to the poor quality of the uncontrolled studies and their tendency to report positive results. The utilization of oral methadone for noncancer pain is based on primarily uncontrolled literature. Well-designed controlled trials may provide more accurate information on the drug's efficiency in pain syndromes and in particular neuropathic pain.

[1]  A. Neil.  Morphine- and methadone-tolerant mice differ in cross-tolerance to other opiates , 1982, Naunyn-Schmiedeberg's Archives of Pharmacology.

[2]  J. Morley,et al.  Low-dose methadone has an analgesic effect in neuropathic pain: a double-blind randomized controlled crossover trial , 2003, Palliative medicine.

[3]  Andrea Furlan,et al.  Updated Method Guidelines for Systematic Reviews in the Cochrane Collaboration Back Review Group , 2003, Spine.

[4]  P. Walker,et al.  High dose methadone and ventricular arrhythmias: a report of three cases , 2003, Pain.

[5]  R. Cruciani,et al.  Ultra-low dose oral naltrexone decreases side effects and potentiates the effect of methadone. , 2003, Journal of pain and symptom management.

[6]  P. Demaria.  Methadone Drug Interactions , 2003 .

[7]  P. Manfredi.  Opioids versus antidepressants in postherpetic neuralgia: A randomized, placebo-controlled trial , 2003, Neurology.

[8]  D. Moulin.  Use of methadone for neuropathic pain. , 2003, Pain research & management.

[9]  E. Ernst,et al.  Methadone‐related deaths in Western Australia 1993–99 , 2002, Australian and New Zealand journal of public health.

[10]  J. Gardner-Nix.  Opioids causing peripheral edema. , 2002, Journal of pain and symptom management.

[11]  S. Tsui,et al.  Long-term therapy of chronic non-malignant pain with potent opioids in an active police officer , 2002, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[12]  J. Katz,et al.  Methadone for Phantom Limb Pain , 2002, The Clinical journal of pain.

[13]  E. Bruera,et al.  Methadone use in cancer patients with pain: a review. , 2002, Journal of palliative medicine.

[14]  J. Clark,et al.  A Case of a Methadone-Induced Movement Disorder , 2001, The Clinical journal of pain.

[15]  A. Furlan,et al.  Chemical Sympathectomy for Neuropathic Pain: Does it Work? Case Report and Systematic Literature Review , 2001, The Clinical journal of pain.

[16]  Y. Shir,et al.  Methadone is safe for treating hospitalized patients with severe pain , 2001, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[17]  A. Furlan,et al.  Gabapentin for Neuropathic Pain: Systematic Review of Controlled and Uncontrolled Literature , 2001, The Clinical journal of pain.

[18]  M. Choinière,et al.  Successful use of methadone in the treatment of chronic neuropathic pain arising from burn injuries: a case-study. , 2001, Burns : journal of the International Society for Burn Injuries.

[19]  H. Hays.  High dosing methadone and a possible relationship to serious cardia arrhythmias. , 2001, Pain research & management.

[20]  M. Mccaffery,et al.  Pain Control: The Merits of Methadone , 2000 .

[21]  M. Mccaffery,et al.  The merits of methadone. , 2000, The American journal of nursing.

[22]  M. Wallace,et al.  Opioid Substitution to Improve the Effectiveness of Chronic Noncancer Pain Control: A Chart Review , 2000, Anesthesia and analgesia.

[23]  E. Bruera,et al.  Opioid type and other clinical predictors of laxative dose in advanced cancer patients: a retrospective study. , 1998, Journal of palliative medicine.

[24]  E. Bruera,et al.  Reduction in constipation and laxative requirements following opioid rotation to methadone: a report of four cases. , 1999, Journal of pain and symptom management.

[25]  S. Mercadante,et al.  Rapid switching from morphine to methadone in cancer patients with poor response to morphine. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  H. Hays,et al.  Use of Methadone in Treating Chronic Noncancer Pain , 1999 .

[27]  S. Mercadante,et al.  Morphine versus methadone in the pain treatment of advanced-cancer patients followed up at home. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  E. Bruera,et al.  Equianalgesic dose/ratio between methadone and other opioid agonists in cancer pain: comparison of two clinical experiences. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[29]  N. Hagen,et al.  Cancer pain emergencies: a protocol for management. , 1997, Journal of pain and symptom management.

[30]  S. Mercadante,et al.  Treatment of pain in chronic bowel subobstruction with self-administration of methadone , 1997, Supportive Care in Cancer.

[31]  C. Stein.  Opioid Treatment of Chronic Nonmalignant Pain1 , 1997, Anesthesia and analgesia.

[32]  E. Zecca,et al.  Clinical experience with oral methadone administration in the treatment of pain in 196 advanced cancer patients. , 1996, Journal of Clinical Oncology.

[33]  E. Bruera,et al.  Opioid rotation in patients with cancer pain: A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine , 1996, Cancer.

[34]  S. Mercadante,et al.  Patient-controlled analgesia with oral methadone in cancer pain: preliminary report. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

[35]  J. Gardner-Nix.  Oral methadone for managing chronic nonmalignant pain. , 1996, Journal of pain and symptom management.

[36]  A R Jadad,et al.  Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.

[37]  S. Mercadante.  Dantrolene treatment of opioid-induced myoclonus. , 1995, Anesthesia and analgesia.

[38]  K. Foley,et al.  Opioid pharmacotherapy in the management of cancer pain. A survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administration , 1995, Cancer.

[39]  E. Bruera,et al.  Custom-made capsules and suppositories of methadone for patients on high-dose opioids for cancer pain , 1995, Pain.

[40]  E. Bruera,et al.  Use of methadone in a highly tolerant patient receiving parenteral hydromorphone. , 1995, Journal of pain and symptom management.

[41]  B. Galer,et al.  The efficacy of opioids in cancer pain syndromes , 1994, Pain.

[42]  M. Finnegan,et al.  Successful use of methadone in nociceptive cancer pain unresponsive to morphine , 1994, Palliative medicine.

[43]  R. Portenoy,et al.  Cancer pain management current strategy , 1993, Cancer.

[44]  D. Denson,et al.  Clinical efficacy of methadone in patients refractory to other μ‐opioid receptor agonist analgesics for management of terminal cancer pain. Case presentations and discussion of incomplete cross‐tolerance among opioid agonist analgesics , 1993, Cancer.

[45]  E. Bruera,et al.  Methadone in the management of cancer pain: a review , 1993, Pain.

[46]  T. Gin,et al.  A Double-Blind Randomised Trial Comparing Postoperative Analgesia after Perioperative Loading doses of Methadone or Morphine , 1992, Anaesthesia and intensive care.

[47]  E. Kalso,et al.  Chronic use of opioids in intractable facial pain. A case report. , 1991, Acta odontologica Scandinavica.

[48]  T. Crowley,et al.  Chronic pain and substance abuse: a pilot study of opioid maintenance. , 1990, Journal of substance abuse treatment.

[49]  L. Grochow,et al.  Does intravenous methadone provide longer lasting analgesia than intravenous morphine? A randomized, double-blind study , 1989, Pain.

[50]  F. De Conno,et al.  A randomized study on oral administration of morphine and methadone in the treatment of cancer pain. , 1986, Journal of pain and symptom management.

[51]  M. Cousins,et al.  A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer , 1986, Pain.

[52]  J. Lamberty,et al.  A Double‐blind Comparison of the Efficacy of Methadone and Morphine in Postoperative Pain Control , 1986, Anesthesiology.

[53]  J. Säwe.  High-Dose Morphine and Methadone in Cancer Patients , 1986, Clinical pharmacokinetics.

[54]  R. Bick.  Role of antithrombin III in clinical management of pulmonary embolization. , 1984, The American journal of medicine.

[55]  T. Ferrer-Brechner,et al.  Combination therapy with ibuprofen and methadone for chronic cancer pain. , 1984, The American journal of medicine.

[56]  M. Stone,et al.  METHADONE: AN EFFECTIVE AGENT IN MANAGING INTRACTABLE PAIN AS A SYMPTOM OF PSYCHOTIC ANGER , 1982, Annals of the New York Academy of Sciences.

[57]  H. Breivik,et al.  Clinical Evaluation of Combined Treatment with Methadone and Psychotropic Drugs in Cancer Patients , 1982, Acta anaesthesiologica Scandinavica. Supplementum.

[58]  G. Hanks,et al.  Patient-controlled dose regimen of methadone for chronic cancer pain. , 1981, British medical journal.

[59]  D. Ettinger,et al.  Important clinical pharmacologic considerations in the use of methadone in cancer patients. , 1979, Cancer treatment reports.

[60]  P. Symonds.  Methadone and the elderly. , 1977, British medical journal.

[61]  R. Houde,et al.  A dinical eomparison of the analgesie effects of methadone and morphine administered intramuseularly, and oforally and parenterally administered methadone , 1967, Clinical pharmacology and therapeutics.